
You can purchase shares of Trex Bio (NASDAQ:TRXB) through any online brokerage.
Other companies in Trex Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Trex Bio has a consensus price target of $29.25.
The stock price for Trex Bio (NASDAQ: TRXB) is $13.67 last updated November 13, 2026 at 4:00 PM EST.
There are no upcoming dividends for Trex Bio.
Trex Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Trex Bio.
Trex Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Trex Bio Inc is a clinical-stage biopharmaceutical company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines designed to restore immune balance and promote tissue repair to address unmet needs of patients...